Roles of Sirt1 and its modulators in diabetic microangiopathy: A review

Area of Science:

• Endocrinology and Metabolism
• Vascular Biology
• Molecular Biology

Background:

• Diabetic microangiopathy involves impaired microvascular endothelial function, basement membrane thickening, and microthrombosis, leading to organ damage.
• Sirt1, a deacetylase, regulates cellular processes including oxidative stress, inflammation, and aging, and is downregulated in microangiopathy.
• Current preventive and therapeutic strategies for diabetic complications are insufficient, necessitating novel approaches.

Purpose of the Study:

• To review the background of diabetic microangiopathy and the functions of Sirt1.
• To explore the relationship between Sirt1 and various diabetic microangiopathies.
• To summarize Sirt1 modulators as potential therapeutic targets for ameliorating diabetic microangiopathy.

Main Methods:

• Literature review and synthesis of existing research on Sirt1 and diabetic microangiopathy.
• Analysis of Sirt1's regulatory roles in different cell types within the context of diabetic complications.
• Identification and summary of therapeutic modulators targeting Sirt1.

Main Results:

• Sirt1 plays critical regulatory roles in oxidative stress and inflammation, processes central to diabetic microangiopathy.
• Sirt1 expression is reduced in vascular injury and microangiopathy, suggesting a protective role.
• Modulators targeting Sirt1 have been identified as potential agents to ameliorate diabetic microangiopathy.

Conclusions:

• Targeting Sirt1 represents a promising new therapeutic strategy for diabetic microangiopathy.
• Understanding Sirt1's regulatory mechanisms is crucial for developing effective treatments.
• Sirt1 modulation offers a potential avenue for preventing and treating diabetic vascular complications.